Skip to main content
Dennis Selkoe, MD, Neurology, Boston, MA

Dennis J Selkoe MD


The Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical School; Co-Director, Center for Neurologic Diseases, Department of Neurology Brigham and Women’s Hospital.

Join to View Full Profile
  • 60 Fenwood RoadBTM 10 - 10002SBoston, MA 02115

  • Phone+1 617-525-5260

Dr. Selkoe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1974 - 1975
  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1972 - 1973
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 1969 - 1970
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1969

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1974 - 2025
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2005
  • Super Doctor SuperDoctors.com
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Journal Articles

  • MicroRNA-132 Provides Neuroprotection for Tauopathies via Multiple Signaling Pathways  
    Dennis Selkoe, MD, Acta Neuropathologica

Authored Content

  • CMS Made the Wrong Decision on Aduhelm. But There Might Be a Silver LiningApril 2022

Press Mentions

  • Alzheimer's Lecanemab Treatment up to 36 Months Supported by Extension Study
    Alzheimer's Lecanemab Treatment up to 36 Months Supported by Extension StudyApril 6th, 2025
  • There Is No ‘Amyloid Cabal’ in Alzheimer’s Research
    There Is No ‘Amyloid Cabal’ in Alzheimer’s ResearchFebruary 14th, 2025
  • An Open Letter to Dennis J. Selkoe, M.D.
    An Open Letter to Dennis J. Selkoe, M.D.December 20th, 2024
  • Join now to see all

Grant Support

  • Biology of Native Alpha-Synuclein Tetramers in Parkinson's DiseaseBRIGHAM AND WOMEN'S HOSPITAL2014–2025
  • Presenilin Biology and the Mechanisms of Alzheimer's DiseaseBRIGHAM AND WOMEN'S HOSPITAL1998–2025
  • Presenilin Biology and the Mechanisms of Alzheimer's DiseaseBRIGHAM AND WOMEN'S HOSPITAL1998–2025
  • Presenilin Biology and the Mechanisms of Alzheimer's DiseaseBRIGHAM AND WOMEN'S HOSPITAL1998–2025
  • Presenilin Biology and the Mechanisms of Alzheimer's DiseaseBRIGHAM AND WOMEN'S HOSPITAL1998–2025
  • Presenilin Biology and the Mechanisms of Alzheimer's DiseaseBRIGHAM AND WOMEN'S HOSPITAL1998–2025
  • Presenilin Biology and the Mechanisms of Alzheimer's DiseaseBRIGHAM AND WOMEN'S HOSPITAL1998–2025
  • Presenilin Biology and the Mechanisms of Alzheimer's DiseaseBRIGHAM AND WOMEN'S HOSPITAL1998–2025
  • Presenilin Biology and the Mechanisms of Alzheimer's DiseaseBRIGHAM AND WOMEN'S HOSPITAL1998–2025
  • Presenilin Biology and the Mechanisms of Alzheimer's DiseaseBRIGHAM AND WOMEN'S HOSPITAL1998–2025
  • PROTEIN-PROTEIN Interactions In The Biology Of Beta-AppNational Institute On Aging2008–2011
  • Aging In The Brain: The Role Of The Fibrous ProteinsNational Institute On Aging2007–2011
  • Pathogenic Mechanisms Of Cell-Derived Abeta OligomersNational Institute On Aging2006–2011
  • Alpha-Synuclein, PUFA And Membrane Vesicles In Health And Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2007–2010
  • Amyloid B-Protein And Immune Markers In Human BloodNational Center For Research Resources2007–2008
  • PROTEIN-PROTEIN Interactions In The Biology Of Beta APPNational Institute On Aging2003–2007
  • Alpha-Synuclein, PUFA And Membrane Vesicles-Health/PdNational Institute Of Neurological Disorders And Stroke2006
  • Aging In The Brain-Role Of The Fibrous ProteinsNational Institute On Aging2003–2006
  • Amyloid Precursor Protein In Human BloodNational Center For Research Resources2004–2005
  • Aging In The Brain-Role Of The Fibrous ProteinsNational Institute On Aging2002
  • Mechanism And Inhibition Of Native Amyloid Beta Aggregation In CellsNational Institute On Aging1999–2002
  • Protein/Protein Interactions In The Biology Of Beta AmylNational Institute On Aging1999–2001
  • Aging In The Brain--Role Of The Fibrous ProteinsNational Institute On Aging1992–2000
  • Protein/Protein Interactions In The Biology Of Beta APPNational Institute On Aging1995–1998
  • Regulation Of Amyloid Beta Production In Health And Alzheimer'S DiseaseNational Institute On Aging1994–1998
  • Leadership And Excellence In Alzheimers DiseaseNational Institute On Aging1994
  • Aging In The Brain: Role Of The Fibrous ProteinsNational Institute On Aging1991–1993
  • Leadership And Excellence In Alzheimer'S DiseaseNational Institute On Aging1988–1993
  • Molecular Pathology Of Alzheimer Paired Helical FilamentNational Institute On Aging1987–1989
  • Aging In The Brain--Role Of The Fibrous ProteinsNational Institute On Aging1985–1989
  • Purification Of Paired Helical FilamentsNational Institute On Aging1985–1988
  • Molecular Pathology Of Alzheimer Paired Helical FilamentNational Institute Of Neurological Disorders And Stroke1985–1986
  • Molecular Pathology Of Alzheimer Paired Helical FilamentNational Institute Of Neurological Disorders And Stroke1985

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: